The advantage of NOAC over warfarin could be observed in the form of the lower risk of all-cause mortality and major bleeding (BARC ≥ 3), with marginal significance.
← all excerpts
Efficacy and Safety of Antithrombotic Therapy With Oral Anticoagulants in Real-World Elderly Patients With Acute Coronary Syndrome and Atrial Fibrillation.
1
—
—